Novel fusidic acid derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030087887A1
SERIAL NO

10100992

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of the general formula I 1 wherein R.sub.1 is hydrogen, halogen, CH.sub.3, CH.sub.2--OH, COOH, CH.sub.2--OSO.sub.3, CH.sub.2--NH(CH.sub.2).sub.a--R.sub.10, or C(.dbd.O)--NH--(CH.sub.2).sub.a--R.sub.10 wherein R.sub.10 is --NH.sub.2, --NH--(CH.sub.2).sub.b--NH.sub.2, --NH--(CH.sub.2).sub.b--NH--(CH.sub.2).-sub.c--NH.sub.2, --NH--(CH.sub.2).sub.b--NH--(CH.sub.2).sub.c--NH--(CH.sub-.2).sub.d--NH.sub.2, --NH--(CH.sub.2).sub.b--NH--(CH.sub.2).sub.c--NH--(CH-.sub.2).sub.d--NH(CH.sub.2).sub.e--NH.sub.2, --NH--(CH.sub.2).sub.b--NH--(-CH.sub.2)O--NH--(CH.sub.2).sub.d--NH--(CH.sub.2).sub.e--NH--(CH.sub.2).sub-.f--NH.sub.2, a saturated or unsaturated heterocyclic ring comprising 1 or 2 heteroatoms, or --NH--(CH.sub.2).sub.b--R.sub.11, wherein R.sub.11 is a saturated or unsaturated heterocyclic ring comprising 1 or 2 heteroatoms, and a, b, c, d, e and f are the same or different and individually represent integers of from 1 to 5; R.sub.2 is hydrogen, halogen, --OH or --OR.sub.12, wherein R.sub.12 is SO.sub.3, C.sub.1-6 alkyl or C.sub.1-6 acyl, --NH--(CH.sub.2).sub.a--R.su-b.10; R is hydrogen, halogen, a lipophilic group, --NH.sub.2--(CH.sub.2).sub.a---R.sub.10 or CH.sub.2--NH--(CH.sub.2).sub.a--R.sub.10; R.sub.4, R.sub.5, R.sub.6, R.sub.7 and R.sub.9 are the same or different and individually represent hydrogen, halogen, --OH, --OSO.sub.3 or --NH--(CH.sub.2).sub.a--R.sub.10; R.sub.3 and R.sub.8 are the same or different and individually represent hydrogen, halogen, --OH or OSO.sub.3; and the dotted lines between carbon atoms 1 and 2, 13 and 17, 16 and 17, and 17 and 20 indicate the presence of a single or double bond; provided that at least one and not more than two of R, R.sub.1, R.sub.2, R.sub.4, R.sub.5, R.sub.6, R.sub.7 or R.sub.9 is --NH--(CH.sub.2).sub.a---R.sub.10, CH.sub.2--NH--(CH.sub.2).sub.a--R.sub.10 or C(.dbd.O)--NH--(CH.sub.2).sub.a--R.sub.10, and the others are hydrogen, --OH or --OSO.sub.3, or (for R.sub.2)--OR.sub.12; and further provided that at least one and not more than four of R.sub.2--R.sub.9 are --OH or --OSO.sub.3; and pharmaceutically acceptable salts and esters thereof are active against a broad spectrum of microorganisms, and may therefore be used in the treatment of microbial infections.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LEO PHARMACEUTICAL PRODUCTS LTD A/S(LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) INDUSTRIPARKEN 55 DK-2750 BALLERUP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Duvold, Tore Frederiksberg, DK 8 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation